Cargando…

S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE

BACKGROUND: There is converging evidence that youths at clinical high risk (CHR) are not only likely to develop the first episode of psychosis but also to develop poor physical outcomes. Some physical health risk factors - such as smoking - have been shown to increase the probability of a frank onse...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Micheli, Andrea, van Lawick van Pabst, Albertine, Yossef, Enass, McGuire, Philip, Fusar-Poli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234667/ http://dx.doi.org/10.1093/schbul/sbaa031.220

Ejemplares similares

M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES
por: Oliver, Dominic, et al.
Publicado: (2020)

S150. EMOTIONAL BEHAVIOUR IN HIGH-RISK AND FIRST-EPISODE PSYCHOSIS
por: Falkenberg, Irina, et al.
Publicado: (2020)

S120. CANDIDATE FACTORS MAINTAINING SOCIAL ANXIETY IN PSYCHOTIC EXPERIENCES: A SYSTEMATIC REVIEW
por: Aunjitsakul, Warut, et al.
Publicado: (2020)

T97. REAL WORLD IMPLEMENTATION OF A TRANSDIAGNOSTIC RISK CALCULATOR FOR THE AUTOMATIC DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN CLINICAL ROUTINE
por: Oliver, Dominic, et al.
Publicado: (2020)

T109. TRAVERSING THE TRANSDIAGNOSTIC GAP BETWEEN DEPRESSION, MANIA AND PSYCHOSIS WITH NATURAL LANGUAGE PROCESSING
por: Patel, Rashmi, et al.
Publicado: (2020)

T127. GENDER DIFFERENCES IN CLINICAL PRESENTATION AND ILLICIT SUBSTANCE USE DURING FIRST EPISODE PSYCHOSIS: AN ELECTRONIC CASE REGISTER NATURAL LANGUAGE PROCESSING ANALYSIS
por: Irving, Jessica, et al.
Publicado: (2020)

S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY
por: Richter, Anja, et al.
Publicado: (2020)

S192. EFFECTS OF NICOTINE INTAKE ON NEUROPLASTICITY IN SMOKING AND NON-SMOKING PATIENTS WITH SCHIZOPHRENIA
por: Pross, Benjamin, et al.
Publicado: (2020)

M154. INTRA- AND INTER-SCANNER RELIABILITY OF GRAY MATTER VOLUME AND CORTICAL THICKNESS ESTIMATES: IMPLICATIONS FOR MULTICENTRE IMAGING STUDIES IN PSYCHOSIS
por: Hedges, Emily, et al.
Publicado: (2020)

S92. REASONS TO START SMOKING CANNABIS: A CASE CONTROL-ANALYSIS FROM THE EUGEI STUDY
por: Spinazzola, Edoardo, et al.
Publicado: (2020)

S93. ADHD SYMPTOMS AND DAILY SMOKING AT AGE 15–16 YEARS AND PSYCHOTIC DISORDER IN EARLY ADULTHOOD. FINDINGS FROM THE NORTHERN FINLAND BIRTH COHORT 1986 STUDY
por: Niemelä, Solja, et al.
Publicado: (2020)

S231. A NETWORK META-ANALYSIS ON SOCIAL COGNITION TRAINING FOR PEOPLE WITH PSYCHOTIC DISORDER: RELATIVE EFFICACY, MODERATORS, AND LONG-TERM EFFECTS
por: Nijman, Saskia, et al.
Publicado: (2020)

Covid-19 vaccines after 12 weeks of pregnancy helps to protect infants as well as mothers
por: Zilver, Sanne, et al.
Publicado: (2023)

T139. OXYTOCIN ENHANCES NEURAL EFFICIENCY IN INFERRING OTHERS’ SOCIAL EMOTIONS IN PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Schmidt, André, et al.
Publicado: (2020)

S118. TRANSDIAGNOSTIC SYMPTOM DIMENSIONS OF PSYCHOSIS AND THE PREDICTIVE ROLE OF PREMORBID ADJUSTMENT AND COGNITIVE CHARACTERISTICS IN THE MULTINATIONAL EU-GEI STUDY
por: Ferraro, Laura, et al.
Publicado: (2020)

S7. INVESTIGATING THE LINK BETWEEN THE PERIPHERAL ENDOCANNABINOID SYSTEM AND CENTRAL GLUTAMATERGIC NEUROTRANSMISSION IN EARLY PSYCHOSIS: A 7T-MRS STUDY
por: Minichino, Amedeo, et al.
Publicado: (2020)

S188. VISUAL ATTENTION IN EARLY-ONSET SCHIZOPHRENIA AND OTHER NEURODEVELOPMENTAL DISORDERS: THE IMPACT OF SPEAKING WHILE LOOKING AT PICTURES OF SOCIAL INTERACTIONS – EVIDENCE FROM EYE TRACKING DATA
por: Ioannou, Chara, et al.
Publicado: (2020)

S78. TIME PREDICTION AND SENSE OF SELF: LACK OF FLEXIBILITY IN PATIENTS WITH SCHIZOPHRENIA
por: Giersch, Anne, et al.
Publicado: (2020)

S53. DELINEATING SOCIAL COGNITION IN AUTISM AND PSYCHOSIS
por: Ziermans, Tim, et al.
Publicado: (2020)

S109. FEASIBILITY AND ACCEPTABILITY OF ACCEPTANCE AND COMMITMENT THERAPY IN DAILY LIFE (ACT-DL): PATIENTS’ PERSPECTIVES
por: van Aubel, Evelyne, et al.
Publicado: (2020)

T82. THE IMPACT OF SMOKING ON LIFE EXPECTANCY IN PSYCHOTIC DISORDERS, AN ELECTRONIC CASE REGISTER COHORT STUDY
por: Chesney, Edward, et al.
Publicado: (2020)

S193. EFFICACY AND SAFETY OF TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATING NEGATIVE SYMPTOMS IN SCHIZOPHRENIA: THE FOLLOW-UP PHASE
por: Valiengo, Leandro, et al.
Publicado: (2020)

S116. PRAGMATIC COMPREHENSION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Parola, Alberto, et al.
Publicado: (2020)

S238. PATIENT ENGAGEMENT TO EARLY INTERVENTION IN PSYCHOSIS SERVICES: RETROSPECTIVE ANALYSIS OF ENGAGEMENT PATTERNS
por: Crocker, Candice, et al.
Publicado: (2020)

S223. DETERMINANTS OF SUSTAINED UNEMPLOYMENT IN FORMERLY EMPLOYED SCHIZOPHRENIA PATIENTS
por: Fundora-Trujillo, Cynthia, et al.
Publicado: (2020)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

S221. THE EFFICACY OF LUMATEPERONE 42 MG IN THE TREATMENT OF SCHIZOPHRENIA SYMPTOMS ASSOCIATED WITH SOCIAL FUNCTIONING: POST HOC ANALYSIS OF AN ACUTE PLACEBO- AND ACTIVE-CONTROLLED TRIAL
por: Vanover, Kimberly, et al.
Publicado: (2020)

S176. A PRELIMINARY INVESTIGATION OF COMT GENE INVOLVEMENT IN COGNITIVE FLEXIBILITY AND ATTENTION IN SCHIZOPHRENIA SPECTRUM DISORDERS
por: Morris, Kim, et al.
Publicado: (2020)

S86. THE RISK OF PHYSICAL HEALTH MULTIMORBIDITY IN PATIENTS WITH PSYCHOSIS: SYSTEMATIC REVIEW AND META-ANALYSIS
por: Rodrigues, Myanca, et al.
Publicado: (2020)

S243. RACIAL AND ETHNIC DIFFERENCES IN PATHWAY TO CARE AND BASELINE CHARACTERISTICS IN EARLY INTERVENTION SERVICES FOR PSYCHOSIS IN NEW YORK STATE
por: van der Ven, Els, et al.
Publicado: (2020)

Intention to receive COVID-19 vaccine during pregnancy: A systematic review and meta-analysis
por: Nassr, Ahmed A., et al.
Publicado: (2022)

S44. NEUROBIOLOGICAL FINGERPRINTS OF COGNITIVE SUBTYPES IN RECENT ONSET PSYCHOSIS PATIENTS
por: Wenzel, Julian, et al.
Publicado: (2020)

S83. MORTALITY, REVASCULARIZATION AND CARDIOPROTECTIVE PHARMACOTHERAPY AFTER ACUTE CORONARY SYNDROME IN PATIENTS WITH PSYCHOTIC DISORDERS: A POPULATION-BASED COHORT STUDY
por: Chung Chang, Wing, et al.
Publicado: (2020)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

S90. A SYSTEMATIC REVIEW AND META-ANALYSIS OF PHARMACOLOGICAL INTERVENTIONS FOR REDUCTION OF WEIGHT GAIN IN PEOPLE WITH SCHIZOPHRENIA: 2019 UPDATE
por: Agarwal, Sri Mahavir, et al.
Publicado: (2020)

S143. NEURAL MECHANISMS OF ROBOT-INDUCED HALLUCINATIONS IN HEALTHY PARTICIPANTS AND SYMPTOMATIC HALLUCINATIONS OF NEUROLOGICAL AND PSYCHIATRIC ORIGIN
por: Blondiaux, Eva, et al.
Publicado: (2020)

T175. THE GUT-MICROBIOTA AS A TARGET FOR THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CONTROLLED TRIALS OF ADD-ON STRATEGIES
por: Minichino, Amedeo, et al.
Publicado: (2020)

S173. GENOME-WIDE ASSOCIATION STUDIES OF SCHIZOPHRENIA AND BIPOLAR DISORDER IN A DIVERSE COHORT OF US VETERANS
por: Bigdeli, Tim, et al.
Publicado: (2020)

S94. PREDICTION OF CANNABIS RELAPSE IN CLINICAL HIGH-RISK INDIVIDUALS AND RECENT ONSET PSYCHOSIS - PRELIMINARY RESULTS FROM THE PRONIA STUDY
por: Penzel, Nora, et al.
Publicado: (2020)

S219. SINGLE-SUBJECT PREDICTION OF FUNCTIONAL OUTCOMES ACROSS DIAGNOSTIC GROUPS USING CLINICAL DATA
por: Rosen, Marlene, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tblop6v5fuf77ll6j8c7ou222e